Disclosures for "Semaglutide Impacts Proteomic Signatures Related to Dementia Risk in the SELECT Cardiovascular Outcomes Trial"
-
Dr. Mystkowski has received personal compensation for serving as an employee of Novo Nordisk. Dr. Mystkowski has stock in Novo Nordisk.
-
Marti Jimenez Mausbach has received personal compensation for serving as an employee of Novo Nordisk. Marti Jimenez Mausbach has stock in Novo Nordisk.
-
Mr. Refsgaard has stock in Novo Nordisk.
-
Dr. Martino has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Martino has stock in Novo Nordisk. Dr. Martino has stock in Roche. Dr. Martino has stock in Eli Lilly.
-
Dr. Leon has received personal compensation for serving as an employee of Novo Nordisk A/S Copenhagen. Dr. Leon has stock in Novo Nordisk. Dr. Leon has stock in Pharma Mar.
-
The institution of Dr. Tijms has received research support from EISAI. The institution of Dr. Tijms has received research support from Novonordisk. Dr. Tijms has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Paterson has received personal compensation for serving as an employee of Standard BioTools. Dr. Paterson has received personal compensation for serving as an employee of SomaLogic. Dr. Paterson has stock in Standard BioTools. Dr. Paterson has stock in SomaLogic. Dr. Paterson has received intellectual property interests from a discovery or technology relating to health care.